Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Breaking News

CVS Health stock tumbles as earnings, guidance miss expectations

Laboratorios Farmaceuticos ROVI (ROVI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
84.300 +1.600    +1.93%
30/04 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Spain
ISIN:  ES0157261019 
  • Prev. Close: 84.300
  • Open: 82.750
  • Day's Range: 82.650 - 84.950
Laborat.Rovi 84.300 +1.600 +1.93%

ROVI Recent Sentiments

 
This page contains information on users’ sentiments for the Laboratorios Farmaceuticos ROVI stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
May 01, 2024 MANUEL ESCUDERO...   84.300 0.00%
Apr 30, 2024 Gerardo Prieto   84.150 -0.18%
Apr 30, 2024 Esteban Martín   84.450 -0.18%
Apr 29, 2024 Vicente Tercero   82.950 +1.63%
Apr 29, 2024 DANIEL ZAMBRANO   83.050 +1.51%
Apr 29, 2024 Francisco Javier...   82.400 +2.31%
Apr 29, 2024 emilio fernandez   81.750 -3.12%
Apr 29, 2024 Albert Trepat   83.400 +1.08%
Apr 29, 2024 Fernando Alonso   85.000 Apr 29, 2024 @ 82.700 -2.71%
Apr 26, 2024 Jorge Sierra   84.050 -0.30%
Apr 26, 2024 ANDREU CARMONA   83.950 +0.42%
Apr 25, 2024 Alvaro Cortés   85.100 +0.94%
Apr 25, 2024 Juan Huerta   85.700 -1.63%
Apr 25, 2024 Esteban Martín   85.100 Apr 29, 2024 @ 82.700 -2.82%
Apr 25, 2024 Luis Labrador   83.100 Apr 29, 2024 @ 82.700 -0.48%
Apr 22, 2024 isabelle torrell   79.400 Apr 29, 2024 @ 82.700 +4.16%
Apr 19, 2024 Luis Labrador   79.450 Apr 22, 2024 @ 79.450 0.00%
Apr 18, 2024 Jesús Moscoso   79.550 +5.97%
Apr 18, 2024 Bene Perez   79.100 +6.57%
Apr 16, 2024 Jorge Gómez Magariño   81.700 Apr 22, 2024 @ 79.450 -2.75%
Apr 16, 2024 cesar alfonso sanchez   80.500 -4.72%
Apr 16, 2024 Félix Etombadyambo   82.850 Apr 22, 2024 @ 79.450 +4.10%
Apr 13, 2024 Juan Pastor   82.250 Apr 15, 2024 @ 82.850 -0.73%
Apr 12, 2024 Fhfgv Fghjhj   83.200 +1.32%
Apr 10, 2024 Jesus Mari Albarran...   81.250 +3.75%
Apr 10, 2024 Juanvi Mulet Bayona   81.200 Apr 15, 2024 @ 82.850 -2.03%
Apr 09, 2024 JoseR MD   81.300 +3.69%
Apr 09, 2024 Miguel Gómez   81.000 +4.07%
Apr 09, 2024 javier blanco   80.700 Apr 15, 2024 @ 82.850 +2.66%
Apr 09, 2024 Alex Amor   80.350 Apr 15, 2024 @ 82.850 +3.11%
Apr 05, 2024 Vicente Tercero   81.750 Apr 26, 2024 @ 85.000 +3.98%
Apr 05, 2024 Litik Binadith   80.500 Apr 26, 2024 @ 85.000 +5.59%
Apr 03, 2024 Julen Lacroix   79.200 Apr 26, 2024 @ 85.000 +7.32%
Apr 03, 2024 Rosa Company   78.950 Apr 26, 2024 @ 85.000 +7.66%
Apr 03, 2024 Camilo Castillo   78.650 Apr 26, 2024 @ 85.000 +8.07%
Apr 03, 2024 emilio fernandez   79.750 Apr 26, 2024 @ 85.000 -6.58%
Apr 02, 2024 José Antonio Ramos...   82.350 Apr 26, 2024 @ 85.000 +3.22%
Apr 02, 2024 Aitor Alvarado Pipaon   82.250 Apr 08, 2024 @ 82.500 +0.30%
Apr 02, 2024 juan manuel cebrian...   80.900 Apr 08, 2024 @ 82.500 +1.98%
Mar 27, 2024 Francisco Javier...   81.000 Apr 19, 2024 @ 79.400 -1.98%
Mar 27, 2024 Esteban Martín   80.150 Apr 01, 2024 @ 80.900 +0.94%
Mar 26, 2024 J Dani Olid   80.800 Apr 19, 2024 @ 79.400 -1.73%
Mar 25, 2024 Salva Ludeña Lopez   80.600 Apr 19, 2024 @ 79.400 +1.49%
Mar 25, 2024 antonio ginés   79.550 Mar 25, 2024 @ 79.500 -0.06%
Mar 25, 2024 Lau Varela   79.700 Mar 25, 2024 @ 80.400 -0.88%
Mar 25, 2024 antonio oliver garcia   79.700 Mar 25, 2024 @ 80.400 +0.88%
Mar 22, 2024 Bene Perez   79.500 Apr 12, 2024 @ 82.250 +3.46%
Mar 21, 2024 Macarena La Espumosa   77.750 Mar 25, 2024 @ 80.400 +3.41%
Mar 21, 2024 Crisanto Olazarri   76.600 Apr 12, 2024 @ 82.250 +7.38%
Mar 21, 2024 Obenavides GRADA   77.150 Apr 12, 2024 @ 82.250 +6.61%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ROVI Comments

Write your thoughts about Laboratorios Farmaceuticos ROVI
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
juan carlos Villarejo
juan carlos Villarejo Apr 30, 2021 7:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
at 100e
juan carlos Villarejo
juan carlos Villarejo Apr 30, 2021 7:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
rovi at ibex?????
El Feriante
El Feriante Apr 30, 2021 7:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Finally yes!
juan carlos Villarejo
juan carlos Villarejo Apr 30, 2021 6:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
??? ibex 35
juan carlos Villarejo
juan carlos Villarejo Apr 30, 2021 6:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
up ibex 35
juan carlos Villarejo
juan carlos Villarejo Apr 30, 2021 3:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
at 100e
Kim Sant
Kim Sant Oct 20, 2020 2:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Rovi now has not crazy fundamentals, but I like it for the same reason I liked Jinko Solar in August. You can't have a brain that is worth 40 and a muscle that is worth 1.5. Biotechs are the brain, Rovi is the muscle and will heavily profit from the success of that brain since is the executor arm. Jinko Solar in solar is the muscle, solaredge and enphase the brain.
Kim Sant
Kim Sant Oct 20, 2020 2:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
And an interesting pattern is, brain stock raise is always before the muscle one, so catching cheap muscles is as easy as detecting growing brains
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email